Efficacy of COVID-19 vaccination in adult patients with sickle cell disease during the Omicron wave in France

Eur J Haematol. 2023 Sep;111(3):509-512. doi: 10.1111/ejh.14034. Epub 2023 Jun 28.

Julien Derdevet¹, Brigitte Ranque^{1

2

3}, Djamal Khimoud¹, Laure Joseph⁴, Adrien Michon¹, Edouard Flamarion¹, Emmanuel Lafont¹, Anne Corbasson¹, Jacques Pouchot^{1

2}, Jean-Benoît Arlet^{1

2

5

6}, Geoffrey Cheminet^{1

2}

¹ Internal Medicine Department, French National Sickle Cell Referral Center, Hôpital Européen Georges Pompidou, Assistance Publique-Hôpitaux de Paris, Paris, France.
² Faculty of Medicine, Université Paris Cité, Paris, France.
³ Université Paris Cité, Inserm UMR-S970, Paris, France.
⁴ Department of Biotherapy, French National Sickle Cell Disease Referral Center, Hôpital Necker, Assistance Publique-Hôpitaux de Paris, Paris, France.
⁵ Laboratoire d'excellence sur le globule rouge GR-ex, Paris, France.
⁶ INSERM U1163, CNRS 8254, Institut IMAGINE, Hôpital Necker, Assistance Publique-Hôpitaux de Paris, Paris, France.

No abstract available

Publication types